Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

6 results about "Expectorant" patented technology

Any agent that promotes ejection of mucus or exudate from the lungs, bronchi and trachea by decreasing mucus viscosity or by increasing the secretion of mucus in a dry, unproductive cough.

An automatic control method and system for a mi-e cough expectorator

This invention discloses an automatic control method and system for a MI-E expectorant machine, comprising: analyzing real-time respiratory data of a patient during the use of the expectorant machine to determine the applicable operating mode of the expectorant machine; diagnosing the consistency between the current operating mode of the expectorant machine and the applicable operating mode, wherein, if the diagnosis result is inconsistent, a working mode switching command is generated to switch the current operating mode of the expectorant machine to the applicable operating mode; or, if the diagnosis result is consistent, a treatment parameter adjustment command is generated to optimize the treatment parameters corresponding to the current operating mode of the expectorant machine. This invention achieves automatic control of the MI-E expectorant machine, effectively improving treatment safety and efficiency.
Owner:BEIJING ANZHEN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV

Compound traditional Chinese medicine essential oil for assisting in intervention of viral pneumonia streptococcus and preparation method thereof

This invention relates to the field of compound essential oils of traditional Chinese medicine, and particularly to a compound essential oil of traditional Chinese medicine for the adjuvant intervention against Streptococcus pneumoniae and its preparation method. The raw materials include the following by weight: 3-8 parts of patchouli essential oil; 2-6 parts of clove essential oil; 2-5 parts of costus root essential oil; 2-6 parts of nard essential oil; 3-7 parts of calamus essential oil; 1-4 parts of asarum essential oil; 3-8 parts of peppermint essential oil; 2-6 parts of artemisia essential oil; 3-7 parts of eupatorium essential oil; 45-80 parts of base oil; 2-5 parts of solubilizer; and 1-3 parts of penetration enhancer. This invention addresses the core issues of "respiratory inflammation, sputum accumulation, and decreased body defense" caused by Streptococcus pneumoniae. Through the scientific formulation of active molecules from nine kinds of Chinese herbal essential oils, a comprehensive synergistic system is formed, which has the functions of "antibacterial and antiviral, anti-inflammatory and lung-clearing, expectorant and cough-relieving, and enhanced defense." It features strong synergistic activity of active molecules, high specificity, high retention and utilization rate of active molecules, safe and convenient use, wide applicability, and simple preparation process.
Owner:LUOBIDA BIOTECHNOLOGY (ANHUI) CO LTD

Biological activity detection method for phlegm-eliminating related drug effects of different processed decoction pieces of pinellia ternate

The invention discloses a biological activity detection method for phlegm-eliminating related drug effects of different processed decoction pieces of pinellia ternate, and relates to the technical field of traditional Chinese medicines. The biological activity detection method comprises the following steps: extracting to-be-detected rhizoma pinelliae processed decoction pieces with water to obtain a test solution; carrying out mixed reaction on the test solution and MUC5AC protein to obtain a reaction solution; and detecting the content of MUC5AC protein in the reaction liquid, and calculating to obtain the in-vitro inhibition rate of the processed decoction pieces of pinellia ternate to be detected on the MUC5AC protein. According to the invention, the inhibition rate of different processed pinellia ternate products on MUC5AC is detected in vitro, so that an objective quantitative index is provided for the clinical phlegm eliminating effect and quality control of the pinellia ternate products, and the safe and effective clinical medication can be guaranteed.
Owner:CAPITAL UNIVERSITY OF MEDICAL SCIENCES

Keratin CF2, its manufacturing method, pharmaceutical composition containing it, and its use

PendingJP2026523114AAntitussive drugsPharmaceutical Substances
The present invention relates to the pharmaceutical technology. Keratin CF2, methods for producing the same, pharmaceutical compositions containing the same and the use thereof are disclosed, and the present invention particularly relates to keratin CF2, nucleic acid molecules encoding the keratin CF2, expression vectors containing the nucleic acid molecule, host cells containing the expression vector or in which the nucleic acid molecule is incorporated into the genome, methods for producing the keratin CF2, pharmaceutical compositions containing the keratin CF2, and the use of the keratin CF2, nucleic acid molecules, expression vectors, host cells or pharmaceutical compositions in the manufacture of antipyretics, analgesics, antitussives, expectorants, anticonvulsants, antiepileptics, antihypertensives, anti-inflammatorys or antivirals.
Owner:INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI

Aromatherapy breathing cream and method of making same

PendingCN122272754A'Orange peel' skinRavensara
This invention discloses an aromatherapy breathing balm and its preparation method. The balm contains compound essential oils: orange peel, tea tree, ravensara leaf, perilla, ginger, sandalwood, marjoram, and rosemary; phase A: aster extract and poria cocos extract; and phase B: sweet almond oil, olive emulsified wax, beeswax, and magnolia bark extract. The resulting cream has a uniform texture and a natural plant aroma. This aromatherapy breathing balm combines multiple compound essential oils and traditional Chinese medicine extracts with antitussive, expectorant, and phlegm-reducing effects, and employs a natural preservative system. It is convenient to use, has good stability, low side effects, is safe and non-irritating, and is suitable for adults and children to relieve cough, asthma, and excessive phlegm symptoms. When using, apply it to the skin, or take 1-2g, heat it in water, and inhale the resulting steam.
Owner:HEZHENG (LINYI) BIOTECHNOLOGY CO LTD

A medicinal pipe homologous traditional Chinese medicine composition with the effects of reducing phlegm and resolving masses and a preparation method thereof

PendingCN122163698APowder deliveryPharmaceutical non-active ingredientsHouttuyniaBreast nodules
This invention discloses a medicinal and edible herbal composition with expectorant and nodule-dispersing effects and its preparation method, belonging to the technical field of medicinal and edible herbal compositions. The composition comprises 10-30 parts oyster shell, 10-20 parts tangerine peel, 10-20 parts Poria cocos, 10-20 parts bergamot, 8-18 parts honeysuckle, and 10-30 parts houttuynia cordata. A preferred ratio is 30 parts oyster shell, 15 parts tangerine peel, 15 parts Poria cocos, 15 parts bergamot, 9 parts honeysuckle, and 30 parts houttuynia cordata. Honey and other medicinal and edible excipients can be added. The preparation involves raw material pretreatment, volatile oil extraction, decoction, concentration, molding, and sterilization steps, and can be made into various dosage forms such as powder and granules. The raw materials used in this invention are all food and medicine homologous ingredients, which are safe for long-term use. The formula follows the theory of "softening and dispersing nodules, regulating qi and resolving phlegm, clearing heat and detoxifying". It improves the pathological microenvironment of nodules through related signaling pathways, and can effectively promote the shrinkage or dissipation of benign lung nodules, thyroid nodules and breast nodules. The preparation process is simple and has broad application prospects.
Owner:合肥益智生物科技有限公司